厳選された高品質なAIプロンプト一覧

功利主義と義務論に基づくバランスの取れた分析を提供し、ビジネス上の道徳的ジレンマに対処し、価値観に合致した意思決定を支援します。

Act as a senior corporate ethics consultant to conduct a deep moral assessment of the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has mild but irreversible neurological side effects with long-term use, yet discontinuing the drug would cause severe deterioration for many chronic patients. Please analyze the trade-offs between disclosing information, adjusting pricing, developing alternatives, and assuming social responsibility by integrating utilitarian impacts on overall well-being with deontological respect for patient autonomy and the principle of non-maleficence. Provide a comprehensive action plan that balances commercial sustainability with moral integrity, focusing on how to protect patient rights while ensuring the company's long-term viability.

事業運営における具体的な倫理的ジレンマに対し、功利主義と義務論に基づく包括的な分析フレームワークを提供し、管理者が道徳的に健全な意思決定を行うのを支援します。

Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that a rare side effect of its marketed drug may cause serious health risks with long-term use, but recalling it would lead to bankruptcy and affect thousands of employees' livelihoods, while concealing it violates patient safety principles. Please evaluate the moral weight of three options—public disclosure, partial recall, or complete concealment—by combining the utilitarian view of the greatest happiness for the greatest number with the deontological view of respecting individual rights and the duty of honesty, and provide a specific action recommendation that balances social responsibility and corporate survival, ensuring the decision-making process is transparent and compliant with business ethics norms.

事業運営における道徳的ジレンマに対し、功利主義と義務論に基づくバランスの取れた分析を提供し、管理者がコンプライアンスと社会的責任を兼ね備えた意思決定を行うのを支援します。

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but under-disclosed side effects with long-term use. Continuing sales increases profit but may harm some patients, while recalling it causes massive losses and job cuts. Please evaluate the moral weight of both paths by combining the impact on overall well-being from utilitarianism with the emphasis on the duty of honest disclosure from deontology, and provide a balanced recommendation that considers legal compliance, corporate survival, and social responsibility, avoiding absolute moral judgments and instead offering a decision framework based on stakeholder analysis.

功利主義と義務論の枠組みに基づき、具体的なビジネスシナリオにおける道徳的衝突を分析し、コンプライアンスおよび倫理的な意思決定の助言を提供します。

Act as a corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its high-profit, already marketed drug has minor but long-term side effects. Recalling it would cause massive financial losses and affect shareholder interests, but not recalling it might harm some patients' health. Please evaluate the ethical weights of both recall and non-recall choices by combining two philosophical frameworks: utilitarianism (greatest happiness for the greatest number) and deontology (moral nature of the act itself, such as honesty and non-maleficence). Avoid simple binary judgments; instead, derive the best action path that is morally defensible and aligns with long-term Corporate Social Responsibility (CSR) by weighing the interests of various stakeholders (patients, shareholders, employees, society), and explain the reasoning.

功利主義と義務論の枠組みに基づき、ビジネスの倫理的ジレンマに対する多角的な分析を提供し、管理者が道徳的に健全な意思決定を行うのを支援します。

Act as a corporate ethics consultant to evaluate the following business scenario: A pharmaceutical company discovers its best-selling drug has minor but negligible side effects with long-term use, yet concealing this information would cause a stock crash and impact employee benefits. Analyze the moral risks of concealment using both utilitarian consequentialism and Kantian deontology, weigh shareholder interests against patient safety, and provide a decision recommendation that balances compliance with corporate social responsibility, ensuring logical consistency and adherence to business ethical standards.

功利主義と義務論の枠組みを用いてビジネス上の道徳的ジレンマを分析し、コンプライアンスと人間中心の意思決定アドバイスを提供します。

Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company developing a life-saving drug faces a dilemma regarding whether to partially release clinical trial data to accelerate approval, potentially sacrificing some subjects' privacy for greater public health benefits. Combine the utilitarian principle of maximizing happiness with the deontological respect for individual rights to evaluate the ethical risks of this decision. Provide a balanced solution that considers legal compliance, social responsibility, and long-term brand reputation, avoiding simple binary judgments, and focus on how to balance procedural justice with outcome justice.

具体的なビジネスの倫理的ジレンマに対し、功利主義と義務論に基づくバランスの取れた分析を提供し、管理者が道徳的に健全な意思決定を行えるよう支援します。

Please conduct an ethical analysis for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has a minor but foreseeable side effect with long-term use, increasing cardiovascular risk for patients, but discontinuing the drug would cause病情 worsening for some dependent patients. Please evaluate whether the company should proactively recall the drug and disclose side effects, combining the utilitarian principle of maximizing happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent. Weigh the short-term financial loss against long-term brand trust and legal liability from the perspectives of stakeholders (patients, shareholders, employees, public), and finally provide a specific action recommendation that balances moral responsibility and corporate sustainability, explaining how this recommendation balances the interests of all parties.

功利主義と義務論の枠組みに基づき、ビジネスの倫理的ジレンマに対する多角的な道徳的評価と助言を提供します。

Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company discovers during clinical trials that a drug has minor but long-term neurological side effects, yet it significantly extends the survival of late-stage cancer patients with no alternative therapies. Please analyze how the company should balance shareholder interests, patient health rights, and social responsibility by combining the utilitarian principle of maximizing happiness with the deontological perspective of respecting patient autonomy and the duty of non-maleficence, specifically regarding whether informed consent forms should explicitly mention these side effects, and provide specific communication strategies and ethical decision-making advice ensuring rigorous logic and compliance with modern business ethics standards.

事業運営における具体的な倫理的ジレンマに対し、功利主義と義務論に基づくバランスの取れた分析を提供し、管理者が道徳的に健全な意思決定を行うのを支援します。

Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its best-selling drug has mild but predictable side effects with long-term use, affecting the quality of life for some elderly patients, but discontinuing the drug would lead to more severe health risks. Please evaluate the moral rationality of three options—continuing sales, modifying label warnings, or initiating a recall—by combining the utilitarian principle of maximizing happiness with the deontological requirement of respecting patient autonomy, and provide a balanced recommendation that considers both corporate responsibility and patient well-being, ensuring the analysis is logically rigorous and compliant with business ethics standards.

功利主義と義務論の枠組みを用いてビジネス上の道徳的ジレンマを分析し、コンプライアンスと人間味のある意思決定の助言を提供します。

Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company developing a life-saving new drug faces a situation where clinical trial data is partially missing, yet market demand is urgent. Please analyze the ethical consequences of continuing or pausing the trial by combining utilitarian considerations for the greatest good of the majority with deontological requirements for procedural justice, and provide specific action recommendations that balance legal compliance, social trust, and long-term business sustainability, ensuring the decision-making process is transparent and adheres to the highest industry ethical standards.

功利主義と義務論の枠組みを用いて、ビジネスシナリオ内の道徳的ジレンマを分析し、コンプライアンスと倫理にかなった意思決定のアドバイスを提供します。

Act as a corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its marketed drug has minor but non-fatal side effects with long-term use, yet withdrawing the product would cause the company to go bankrupt and affect thousands of patients relying on it. Please evaluate the moral weight of three options—withdrawal, continued sales with enhanced warnings, or voluntary recall with compensation—by integrating both utilitarian (maximizing overall well-being) and deontological (respecting patient autonomy and informed consent) ethical frameworks. Finally, provide a balanced decision recommendation that considers legal compliance, corporate survival, and patient rights, explaining its ethical justification.

企業運営における具体的な倫理的ジレンマに対し、功利主義と義務論に基づく包括的な分析フレームワークを提供し、管理者が道徳的に健全な意思決定を行えるよう支援します。

Please analyze the following specific ethical dilemma encountered in corporate operations: A pharmaceutical company is deciding whether to launch a new drug with high profit margins but minor long-term side effects immediately. Please evaluate the moral weight of different decision paths by combining the principle of maximum happiness in utilitarianism with the requirement of respecting patient autonomy in deontology, and provide a balanced recommendation that considers both business responsibility and social well-being, ensuring the analysis is logically rigorous and aligns with modern business ethics standards.